Hannah Joseph Hospital Limited (BOM:544687)
India · Delayed Price · Currency is INR 65.10
+0.09 (0.14%)
At close: Feb 12, 2026
Hannah Joseph Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 795.41 | 775.31 | 634.08 | 546.23 | 580.97 | 355.88 |
Other Revenue | 0 | - | - | 0.62 | 0.68 | 0.67 |
| 795.41 | 775.31 | 634.08 | 546.85 | 581.65 | 356.55 | |
Revenue Growth (YoY) | 45.45% | 22.27% | 15.95% | -5.98% | 63.13% | - |
Cost of Revenue | 207.8 | 233.22 | 178.29 | 182.14 | 207.25 | 150.44 |
Gross Profit | 587.62 | 542.09 | 455.79 | 364.71 | 374.4 | 206.11 |
Selling, General & Admin | 31.51 | 28.99 | 20.31 | 17.99 | 18.58 | 17.26 |
Other Operating Expenses | 344.96 | 306.19 | 254.15 | 180.7 | 172.93 | 114.15 |
Operating Expenses | 446.37 | 407.6 | 356.59 | 292.16 | 300.14 | 204.16 |
Operating Income | 141.24 | 134.49 | 99.2 | 72.56 | 74.26 | 1.95 |
Interest Expense | -32.07 | -33.01 | -46.41 | -62.45 | -69.26 | -46.85 |
Interest & Investment Income | 3.28 | 2.46 | 0.49 | 0.21 | 0.1 | 0.03 |
Other Non Operating Income (Expenses) | -0.01 | -0.47 | -0.12 | -1.89 | -1.7 | -1.05 |
EBT Excluding Unusual Items | 112.45 | 103.48 | 53.17 | 8.43 | 3.41 | -45.92 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.27 | -0.19 | - | -0.7 |
Other Unusual Items | - | - | - | 1.9 | - | - |
Pretax Income | 112.44 | 103.47 | 53.43 | 10.15 | 3.41 | -46.62 |
Income Tax Expense | 30.09 | 31.37 | 12.77 | 0.05 | 0.03 | -22.12 |
Net Income | 82.36 | 72.1 | 40.67 | 10.11 | 3.39 | -24.5 |
Net Income to Common | 82.36 | 72.1 | 40.67 | 10.11 | 3.39 | -24.5 |
Net Income Growth | 714.99% | 77.30% | 302.43% | 198.52% | - | - |
Shares Outstanding (Basic) | 17 | 17 | 17 | 13 | 4 | 2 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 13 | 4 | 2 |
Shares Change (YoY) | 24.62% | 0.14% | 24.45% | 236.65% | 125.00% | - |
EPS (Basic) | 4.93 | 4.32 | 2.44 | 0.75 | 0.85 | -13.86 |
EPS (Diluted) | 4.93 | 4.32 | 2.44 | 0.75 | 0.85 | -13.86 |
EPS Growth | 553.96% | 77.05% | 223.37% | -11.33% | - | - |
Free Cash Flow | 89.47 | 72.8 | 56.9 | 38.06 | 147.95 | -12.17 |
Free Cash Flow Per Share | 5.36 | 4.36 | 3.41 | 2.84 | 37.19 | -6.88 |
Gross Margin | 73.88% | 69.92% | 71.88% | 66.69% | 64.37% | 57.81% |
Operating Margin | 17.76% | 17.35% | 15.65% | 13.27% | 12.77% | 0.55% |
Profit Margin | 10.35% | 9.30% | 6.41% | 1.85% | 0.58% | -6.87% |
Free Cash Flow Margin | 11.25% | 9.39% | 8.97% | 6.96% | 25.44% | -3.41% |
EBITDA | 202.42 | 193.17 | 168.47 | 166.03 | 182.89 | 74.71 |
EBITDA Margin | 25.45% | 24.91% | 26.57% | 30.36% | 31.44% | 20.95% |
D&A For EBITDA | 61.18 | 58.67 | 69.27 | 93.47 | 108.62 | 72.76 |
EBIT | 141.24 | 134.49 | 99.2 | 72.56 | 74.26 | 1.95 |
EBIT Margin | 17.76% | 17.35% | 15.65% | 13.27% | 12.77% | 0.55% |
Effective Tax Rate | 26.76% | 30.32% | 23.89% | 0.46% | 0.73% | - |
Revenue as Reported | 20.91 | - | - | 548.97 | 581.75 | 378.7 |
Advertising Expenses | - | 12.38 | 3.93 | 2.95 | 3.82 | 5.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.